Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
The Commonwealth Fund’s Medicare at 50 Years series is now available in its entirety as an e-book. Read it online below or download in two formats, for your Kindle or other e-reader. Send us your feedback at [email protected]